Novag Pharma International
0406.097.824 · rovalta.com · 28/09/2026
NORMAL SITUATION
Novag Pharma International
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result483 k €+3,1 %over 1 year
Equity26,9 M €+1,8 %over 1 year
Overview
Identity
Source · BCE/KBONovag Pharma International is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0406.097.824
- Legal form
- Public limited company
- Contributed capital
- 1 396 446,20 €
- Latest accounts
- 31/12/2022
Signals
ProfitableSolid equityGood liquidityPositive cashflow
Financials
Source · NBB, 45 filingsTrend over 13 financial years
| 2022 | 2021 | 2016 | 2015 | 2014 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| EBITDA | -14,9 k € | +11.7% | -16,9 k € | -16.0% | -14,6 k € | -41.3% | -10,3 k € | +35.9% | -16,1 k € |
| Operating result | -14,9 k € | +11.7% | -16,9 k € | -16.0% | -14,6 k € | -41.3% | -10,3 k € | +35.9% | -16,1 k € |
| Net result | 483 k € | +3.1% | 468,7 k € | +3292% | -14,7 k € | -120% | -6,7 k € | +43.9% | -11,9 k € |
| Balance sheet | |||||||||
| Equity | 26,9 M € | +1.8% | 26,4 M € | +1654% | 1,5 M € | -1.0% | 1,5 M € | -0.4% | 1,5 M € |
| Total assets | 27,1 M € | +1.8% | 26,7 M € | +1432% | 1,7 M € | -12.3% | 2 M € | -0.3% | 2 M € |
| Cash | 16,5 k € | +4.6% | 15,8 k € | -84.4% | 101,1 k € | -13.4% | 116,6 k € | -8.0% | 126,7 k € |
| Debts | 251,1 k € | -1.8% | 255,7 k € | +8.7% | 235,2 k € | -42.6% | 409,9 k € | +8.3% | 378,5 k € |
Board of directors
Source · NBB, accounts to 31/12/20221 active · 12 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Sergio FERRER SALAT DI MIGNI | Director29/06/2016 → 08/05/2028 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
David Ferrer Puig | Director30/11/2018 → 15/05/2024 | |
Mario Rovirosa Escosura | Managing director30/11/2018 → 15/05/2024 |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/07/2023 | 28/07/2022 | 27/08/2021 | 12/08/2020 | 18/07/2019 | 08/01/2019 |
| General meeting | 20/07/2023 | 30/06/2022 | 30/07/2021 | 30/07/2020 | 28/06/2019 | 30/11/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 45 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2022 | 20/07/2023 | 27/07/2023 | French | |
| Full model | 31/12/2021 | 30/06/2022 | 28/07/2022 | French | |
| Full model | 31/12/2020 | 30/07/2021 | 27/08/2021 | French | |
| Full model | 31/12/2019 | 30/07/2020 | 12/08/2020 | French | |
| Full model | 31/12/2018 | 28/06/2019 | 18/07/2019 | French | |
| Full model | 31/12/2017 | 30/11/2018 | 08/01/2019 | French | |
| Full model | 31/12/2016 | 30/06/2017 | 31/08/2017 | French | |
| Full model | 31/12/2015 | 29/06/2016 | 29/08/2016 | French | |
| Full model | 31/12/2014 | 29/06/2015 | 26/08/2015 | French | |
| Full model | 31/12/2013 | 27/06/2014 | 31/07/2014 | French | |
| Full model | 31/12/2012 | 24/06/2013 | 11/07/2013 | French | |
| Full model | 31/12/2011 | 29/06/2012 | 22/08/2012 | French | |
| Full model | 31/12/2010 | 30/06/2011 | 30/08/2011 | French | |
| Full model | 31/12/2009 | 30/06/2010 | 10/08/2010 | French | |
| Full model | 31/12/2008 | 29/06/2009 | 15/07/2009 | French | |
| Full model | 31/12/2007 | 30/06/2008 | 30/07/2008 | French | |
| Full modelCorrection | 31/12/2006 | 30/06/2007 | 14/09/2007 | French | |
| Full model | 31/12/2006 | 30/06/2007 | 29/08/2007 | French | |
| Full model | 31/12/2005 | 08/05/2006 | 09/08/2006 | French | |
| Full model | 31/12/2004 | 22/06/2005 | 07/07/2005 | French | |
| Full model | 31/12/2003 | 30/06/2004 | 06/08/2004 | French | |
| Full model | 31/12/2002 | 30/06/2003 | 31/07/2003 | French | |
| Full model | 31/12/1999 | 10/05/2000 | 11/12/2000 | French | |
| Full model | 31/12/1998 | 10/05/1999 | 29/03/2000 | French | |
| Full model | 31/12/1997 | 11/05/1998 | 27/07/1998 | French | — |
| Full model | 31/12/1996 | 12/05/1997 | 12/09/1997 | French | — |
| Full model | 31/12/1995 | 13/05/1996 | 10/09/1996 | French | — |
| Full model | 31/12/1994 | 08/05/1995 | 07/06/1995 | French | — |
| Full model | 31/12/1993 | 09/05/1994 | 15/07/1994 | French | — |
| Full model | 31/12/1992 | 11/05/1993 | 14/03/1994 | French | — |
| Full model | 31/12/1991 | 11/05/1992 | 21/08/1992 | French | — |
| Full model | 31/12/1990 | 13/05/1991 | 06/06/1991 | French | — |
| Full model | 31/12/1989 | 14/05/1990 | 21/06/1990 | French | — |
| Full model | 31/12/1988 | 08/05/1989 | 12/05/1989 | French | — |
| Full model | 31/12/1987 | 09/05/1988 | 15/06/1988 | French | — |
| Abridged model | 31/12/1986 | 11/05/1987 | 29/06/1987 | French | — |
| Abridged model | 31/12/1985 | 02/06/1986 | 09/07/1986 | French | — |
| Abridged model | 31/12/1984 | 13/05/1985 | 05/07/1985 | French | — |
| m901-p | 31/12/1983 | 14/05/1984 | 05/06/1984 | French | — |
| m901-p | 31/12/1982 | 10/05/1983 | 09/06/1983 | French | — |
| m901-p | 31/12/1981 | 10/05/1982 | 28/05/1982 | French | — |
| m901-p | 31/12/1980 | 01/01/9999 | 19/06/1981 | French | — |
| m901-p | 31/12/1979 | 01/01/9999 | 18/06/1980 | English | — |
| m901-p | 31/12/1978 | 01/01/9999 | 18/06/1979 | French | — |
| m901-p | 31/12/1977 | 01/01/9999 | 29/06/1978 | English | — |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20221 active · 12 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Sergio FERRER SALAT DI MIGNI | Director29/06/2016 → 08/05/2028 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
David Ferrer Puig | Director30/11/2018 → 15/05/2024 | |
Mario Rovirosa Escosura | Managing director30/11/2018 → 15/05/2024 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution27/12/2023Dissolution et liquidation en un seul acte
- Mandates28/04/2023DEMISSIONS, NOMINATIONS
- Mandates20/09/2022DEMISSIONS, NOMINATIONS
- Mandates24/01/2022DEMISSIONS, NOMINATIONS
- Mandates02/07/2019DEMISSIONS, NOMINATIONS
- Mandates09/12/2016DEMISSIONS, NOMINATIONS
- Mandates06/06/2013DEMISSIONS, NOMINATIONS
- Mandates06/06/2013DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings13 filings
Mandates
Sergio FERRER SALAT DI MIGNI
Mario ROVIROSA ESCOSURA
David FERRER PUIG
Sergio Ferrer Salat Serra di Migni
Jorge Ramentol Massana
Juan Fanès Trillo
Sergio Ferrer Salat Serra diMigni
Sergio Ferrer Salat Serrra di Migni
Edualdo MELENDRES-MATA
Eudaldo MELENDRES-MATA
Eudaldo Melendres Mata
Sergio FERRER-SALAT SERRA DI MIGNI
and 1 more mandate
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
Novag Pharma International
Boulevard Louis Schmidt 119, 1040 Etterbeek
Director
Managing director
Director
Director
Managing director
Director
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Boulevard Louis Schmidt 119, 1040 Etterbeek | accounts 2021 → 2022 | Accounts 2022 · 2023-00298595 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Novag Pharma International | accounts 2021 → 2022 | Accounts 2022 · 2023-00298595 |
Events
- 2022Annual accounts 2022483 k €↑
- 2021Annual accounts 2021468,7 k €↑
- 2016Annual accounts 2016-14,7 k €↓
- 2015Annual accounts 2015-6,7 k €↑
- 2014Annual accounts 2014-11,9 k €↑
- 2013Annual accounts 2013-99,9 k €↓
- 2012Annual accounts 2012-11,1 k €↓
- 2011Annual accounts 2011-7,4 k €↓
- 2010Annual accounts 2010412,9 k €↓
- 2009Annual accounts 2009850,8 k €↑
- 2008Annual accounts 2008-474,9 k €↑
- 2007Annual accounts 2007-929,5 k €↓
- 2006Annual accounts 2006-3,3 k €